$599
Tandem, Lexicon, and Vertex Q2 ’24 Earnings; Novartis Sues FDA Over Entresto Generic
A series of cardiometabolic-related news items have been observed from Tandem, Lexicon, Vertex, and Novartis. Below, FENIX provides highlights and insights for the respective news items.